sustained release.

ABSTRACTLiquisolid strategy is otherwise called powder solution technology. It is the system which manages the solubility upgrade of inadequately solvent medications. As nowadays there are numerous medications in the market with poor solvency which prompts poor disintegration and bioavailability, so dissolvability is getting to be rate constraining component in the advancement of new medications. To defeat this issue there are numerous systems yet liquisolid strategy is most encouraging procedure which is talked about in this article. Liquisolid is for the most part made out of medication, non volatile solvent, carrier material, coating material, and disintegrant. In liquisolid strategy carrier and coating material which ought to be in the proportion of 20:1 is blended into the non volatile solvent and after that disintegrant is included and last material is packed into tablets. Henceforth, the liquisolid innovation permits the change of fluid frameworks into strong medication conveyance frameworks. Both quick and managed arrival of medication can likewise be accomplished with the assistance of liquisolid procedure. For sustained release of medication hydrophilic polymer like Hydroxy Propyl Methyl Cellulose can be the best choice. The motivation behind this article is to depict about the liquisolid strategy like basics, classification, preformulation examines, characterization, pre compression contemplates, detailing of tablet, post compression thinks about, points of interest, drawbacks, applications.Keywords: Liquisolid, bioavailability, dissolution, sustained release.

In present work calcium alginate (CA) microbeads encapsulated clonidine hydrochloride was prepared by ionotropic external gelation method in which calcium chloride used as cross-linking agent. Clonidine hydrochloride is a sympatholytic centrally acting α2 adrenergic agonist and imidazoline receptor agonist used to treat high blood pressure, attention deficit hyperactivity disorder, anxiety disorders, migraine, and menopausal flushing but it have very short half life which required some new approach which help to retain it in the body for longer period of time. Calcium alginate microbeads represent a useful tool for oral sustained/ controlled drug delivery. The prepared alginate beads were studied for percent loading efficiency, average particles size, shape and surface morphology, Differential Scanning calorimeter (DSC) and drug release behavior. Chitosan and HPMC incorporated in addition to overcome rapid drug release at higher pH due to its high porosity. Prepared optimized alginate microbeads formulation found to be 356.22±8.1nm average in size, 86.46±2.6% entrapment efficiency. DSC and FT-IR confirm no interaction with the polymers used in the formulation. High concentration of polymer and CaCl2 increase the drug loading efficiency while high concentration of CaCl2  also retard the release of clonidine hydrochloride from the beads. The shape and surface morphology was determined by scanning electron microscopy (SEM) and found the beads in smooth and spherical in shape. In-vitro release study showed that microbeads release 97.85 % drug in 7 hr which was pH dependent and also due to swelling and surface erosion. Microbead release the drug which follow Higuchi matrix diffusion release kinetic. Finally it is concluded that alginate, HPMC and chitosan in combination can be used to prepare microbead to encapsulate clonidine hydrochloride in higher amount. Biodegradable and non toxic nature of polymer make the prepared microbeads suitable for oral administration.